Literature DB >> 24650559

Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle.

Joanna K Dowman1, Laurence J Hopkins2, Gary M Reynolds3, Nikolaos Nikolaou4, Matthew J Armstrong1, Jean C Shaw3, Diarmaid D Houlihan1, Patricia F Lalor3, Jeremy W Tomlinson4, Stefan G Hübscher5, Philip N Newsome6.   

Abstract

Obesity is increasingly prevalent, strongly associated with nonalcoholic liver disease, and a risk factor for numerous cancers. Here, we describe the liver-related consequences of long-term diet-induced obesity. Mice were exposed to an extended obesity model comprising a diet high in trans-fats and fructose corn syrup concurrent with a sedentary lifestyle. Livers were assessed histologically using the nonalcoholic fatty liver disease (NAFLD) activity score (Kleiner system). Mice in the American Lifestyle-Induced Obesity Syndrome (ALIOS) model developed features of early nonalcoholic steatohepatitis at 6 months (mean NAFLD activity score = 2.4) and features of more advanced nonalcoholic steatohepatitis at 12 months, including liver inflammation and bridging fibrosis (mean NAFLD activity score = 5.0). Hepatic expression of lipid metabolism and insulin signaling genes were increased in ALIOS mice compared with normal chow-fed mice. Progressive activation of the mouse hepatic stem cell niche in response to ALIOS correlated with steatosis, fibrosis, and inflammation. Hepatocellular neoplasms were observed in 6 of 10 ALIOS mice after 12 months. Tumors displayed cytological atypia, absence of biliary epithelia, loss of reticulin, alteration of normal perivenular glutamine synthetase staining (absent or diffuse), and variable α-fetoprotein expression. Notably, perivascular tumor cells expressed hepatic stem cell markers. These studies indicate an adipogenic lifestyle alone is sufficient for the development of nonalcoholic steatohepatitis, hepatic stem cell activation, and hepatocarcinogenesis in wild-type mice.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24650559      PMCID: PMC4005975          DOI: 10.1016/j.ajpath.2014.01.034

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  The phenotypes of pluripotent human hepatic progenitors.

Authors:  Eva Schmelzer; Eliane Wauthier; Lola M Reid
Journal:  Stem Cells       Date:  2006-04-20       Impact factor: 6.277

2.  Differential cytokeratin and alpha-fetoprotein expression in morphologically distinct epithelial cells emerging at the early stage of rat hepatocarcinogenesis.

Authors:  L Germain; R Goyette; N Marceau
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

3.  Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin.

Authors:  Kari N Nejak-Bowen; Michael D Thompson; Sucha Singh; William C Bowen; Mohd Jamal Dar; Jaspal Khillan; Chunsun Dai; Satdarshan P S Monga
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

4.  High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.

Authors:  Rohit Kohli; Michelle Kirby; Stavra A Xanthakos; Samir Softic; Ariel E Feldstein; Vijay Saxena; Peter H Tang; Lili Miles; Michael V Miles; William F Balistreri; Stephen C Woods; Randy J Seeley
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

5.  Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.

Authors:  Y Sato; K Nakata; Y Kato; M Shima; N Ishii; T Koji; K Taketa; Y Endo; S Nagataki
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

6.  Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease.

Authors:  Shiqi Yang; Ayman Koteish; Huizhi Lin; Jiawen Huang; Tania Roskams; Valina Dawson; Anna Mae Diehl
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

7.  Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.

Authors:  Rafal P Witek; W Carl Stone; F Gamze Karaca; Wing-Kin Syn; Thiago A Pereira; Kolade M Agboola; Alessia Omenetti; Youngmi Jung; Vanessa Teaberry; Steve S Choi; Cynthia D Guy; John Pollard; Peter Charlton; Anna Mae Diehl
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

8.  Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.

Authors:  Michelle M Richardson; Julie R Jonsson; Elizabeth E Powell; Elizabeth M Brunt; Brent A Neuschwander-Tetri; Prithi S Bhathal; John B Dixon; Martin D Weltman; Herbert Tilg; Alexander R Moschen; David M Purdie; Anthony J Demetris; Andrew D Clouston
Journal:  Gastroenterology       Date:  2007-05-16       Impact factor: 22.682

9.  Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium.

Authors:  Shishir Shetty; Christopher J Weston; Ye H Oo; Nina Westerlund; Zania Stamataki; Janine Youster; Stefan G Hubscher; Marko Salmi; Sirpa Jalkanen; Patricia F Lalor; David H Adams
Journal:  J Immunol       Date:  2011-03-02       Impact factor: 5.422

10.  Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.

Authors:  Matthew J Armstrong; Diarmaid D Houlihan; Louise Bentham; Jean C Shaw; Robert Cramb; Simon Olliff; Paramjit S Gill; James M Neuberger; Richard J Lilford; Philip N Newsome
Journal:  J Hepatol       Date:  2011-05-18       Impact factor: 25.083

View more
  32 in total

Review 1.  Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.

Authors:  Letiția Adela Maria Streba; Cristin Constantin Vere; Ion Rogoveanu; Costin Teodor Streba
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

2.  Dietary Additives and Supplements Revisited: The Fewer, the Safer for Liver and Gut Health.

Authors:  Rachel Golonka; Beng San Yeoh; Matam Vijay-Kumar
Journal:  Curr Pharmacol Rep       Date:  2019-06-10

3.  Palm tocotrienol rich fraction with palm kernel oil supplementation prevents development of liver steatosis in high fat diet ICR mice.

Authors:  Mohd Danial Mohd Efendy Goon; Nur Izzati Zulkanain; Siti Hamimah Sheikh Abdul Kadir; Sharaniza Ab Rahim; Musalmah Mazlan; Normala Abd Latip; Mardiana Abdul Aziz; Norizal Mohd Noor
Journal:  Transl Gastroenterol Hepatol       Date:  2022-01-25

4.  A new preclinical model of western diet-induced progression of non-alcoholic steatohepatitis to hepatocellular carcinoma.

Authors:  Christopher D Green; Cynthia Weigel; Ryan D R Brown; Pierre Bedossa; Mikhail Dozmorov; Arun J Sanyal; Sarah Spiegel
Journal:  FASEB J       Date:  2022-07       Impact factor: 5.834

5.  Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.

Authors:  Yi Shen; Harvey Risch; Lingeng Lu; Xiaomei Ma; Melinda L Irwin; Joseph K Lim; Tamar Taddei; Karen Pawlish; Antoinette Stroup; Robert Brown; Zhanwei Wang; Wei Jia; Linda Wong; Susan T Mayne; Herbert Yu
Journal:  Cancer Causes Control       Date:  2020-02-14       Impact factor: 2.506

Review 6.  Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?

Authors:  Mark A Febbraio; Saskia Reibe; Shabnam Shalapour; Geraldine J Ooi; Matthew J Watt; Michael Karin
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

Review 7.  Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis.

Authors:  Hayato Nakagawa
Journal:  World J Hepatol       Date:  2015-08-18

8.  A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer.

Authors:  Takuma Tsuchida; Youngmin A Lee; Naoto Fujiwara; Maria Ybanez; Brittany Allen; Sebastiao Martins; M Isabel Fiel; Nicolas Goossens; Hsin-I Chou; Yujin Hoshida; Scott L Friedman
Journal:  J Hepatol       Date:  2018-03-21       Impact factor: 30.083

9.  Propofol suppresses cell proliferation in gastric cancer cells through NRF2-mediated polyol pathway.

Authors:  Yajun Cao; Long Fan; Linkai Li; Jiexian Zhou
Journal:  Clin Exp Pharmacol Physiol       Date:  2021-11-09       Impact factor: 2.963

10.  The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Shelley E Harris; Toryn M Poolman; Anastasia Arvaniti; Roger D Cox; Laura L Gathercole; Jeremy W Tomlinson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-08-05       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.